ArticleCancer immunology research2017

Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma.

Linda Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.